Advancements in Early Diagnosis and Personalized Treatment Strategies for Skin Diseases: A Meta-Analysis of Interdisciplinary Approaches Combining Dermatology, Genetics, and Immunology

Several Skin illnesses, including dermatological disorders psoriasis, eczema, and skin cancers, remain serious issues to the health of humankind. Advances in diagnostic technology, treatment practices, and cross-disciplinary studies in the recent past have the potential to revolutionize the management of these diseases. This meta-analysis is aimed to explore the novel developments in early diagnosis and personalized treatment regimens of skin disorders with a focus on integration of dermatology with genetics, immunology, and other clinical sciences. We will address the emerging diagnostic techniques, such as AI-based skin imaging, biomarkers, and genetics, and how they impact the identification and care of disease in its earliest form. Besides, we will examine the latest developments in personalized medicine treatments, such as biologics and targeted therapies, which have been promising to improve outcomes in patients. There is a need for interdisciplinary cooperation between dermatology and immunology, and genetics in order to maximize treatment protocols and advance knowledge in skin biology. This review will also assess preventative strategies, such as genetic testing, lifestyle modifications, and early treatment, in order to mitigate the progression of chronic skin disorders. By collating data across disciplines, this research will yield an integrative summary of dermatological practice of the future and ultimately enhance quality of life in individuals with skin disease and further the boundaries of skin disease science. Besides, in this review, the way that global health initiatives can increase access to new therapies to ensure that technological advancements in dermatologic care become available to diverse groups of people will be discussed. Bridging gaps in healthcare infrastructure, especially in low-resource environments, will be a vital move towards alleviating the global burden of skin disease.